FAST NEWS: Henlius Biotech’s revenue doubles in first quarter
The latest: Shanghai Henlius Biotech Inc. (2696.HK) reported its revenue soared 97.2% to 996 million yuan ($145 million) in the first quarter, according to a business update released on Sunday.…
2696.HK
Recent Articles
RELATED ARTICLES
-
Henlius finds elixir in first profits, scraps A-share IPO
2696.HK
-
FAST NEWS: Henlius expects first-ever annual profit on strong drug sales
2696.HK
-
FAST NEWS: Henlius swings to the black on strong sales growth
2696.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
BeiGene goes for global growth with sales and R&D push
BGNE.US 6160.HK
-
Drug maker Junshi seeks Swiss cure for cash woes
1877.HK 688150.SHG
Discover hidden China stock gems in our weekly newsletter